Next Generation Cancer Diagnostic Devices Market Report – Research, Industry Analysis Reports and Market Demands

Global and China Next Generation Cancer Diagnostic Devices Market Insights, Forecast to 2026

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Market Segments
1.3 Key Next Generation Cancer Diagnostic Devices Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
- 1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Type
- 1.4.2 Next Generation Sequencing
- 1.4.3 qPCR & Multiplexing
- 1.4.4 Lab-on- a- chip (LOAC)
- 1.4.5 Protein Microarrays
- 1.4.6 DNA Microarrays
- 1.4.7 Reverse Transcriptase-PCR (RT-PCR)
1.5 Market by Application
- 1.5.1 Global Next Generation Cancer Diagnostic Devices Market Size Growth Rate by Application
- 1.5.2 Biomarker Development
- 1.5.3 CTC Analysis
- 1.5.4 Proteomic Analysis
- 1.5.5 Epigenetic Analysis
- 1.5.6 Genetic Analysis
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Next Generation Cancer Diagnostic Devices Market Size, Estimates and Forecasts
- 2.1.1 Global Next Generation Cancer Diagnostic Devices Revenue 2015-2026
- 2.1.2 Global Next Generation Cancer Diagnostic Devices Sales 2015-2026
2.2 Global Next Generation Cancer Diagnostic Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Next Generation Cancer Diagnostic Devices Historical Market Size by Region (2015-2020)
- 2.3.1 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.3.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Region (2021-2026)
- 2.4.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Region (2021-2026)
- 2.4.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2021-2026)

3 Global Next Generation Cancer Diagnostic Devices Competitor Landscape by Players

3.1 Global Top Next Generation Cancer Diagnostic Devices Sales by Manufacturers
- 3.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Manufacturers (2015-2020)
- 3.1.2 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2015-2020)
3.2 Global Next Generation Cancer Diagnostic Devices Manufacturers by Revenue
- 3.2.1 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturers (2015-2020)
- 3.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Next Generation Cancer Diagnostic Devices Revenue in 2019
- 3.2.5 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Next Generation Cancer Diagnostic Devices Price by Manufacturers
3.4 Global Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Types
- 3.4.1 Next Generation Cancer Diagnostic Devices Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
- 3.4.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

4.1 Global Next Generation Cancer Diagnostic Devices Market Size by Type (2015-2020)
- 4.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Type (2015-2020)
- 4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Type (2015-2020)
- 4.1.3 Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Next Generation Cancer Diagnostic Devices Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2026)
- 4.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
- 4.2.3 Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

5.1 Global Next Generation Cancer Diagnostic Devices Market Size by Application (2015-2020)
- 5.1.1 Global Next Generation Cancer Diagnostic Devices Sales by Application (2015-2020)
- 5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Application (2015-2020)
- 5.1.3 Next Generation Cancer Diagnostic Devices Price by Application (2015-2020)
5.2 Next Generation Cancer Diagnostic Devices Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2026)
- 5.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2021-2026)

6 China by Players, Type and Application

7 North America

7.1 North America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
7.2 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 7.2.1 North America Next Generation Cancer Diagnostic Devices Sales by Country (2015-2020)
- 7.2.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country (2015-2020)
- 7.2.3 U.S.
- 7.2.4 Canada

8 Europe

8.1 Europe Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
8.2 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 8.2.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country
- 8.2.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country
- 8.2.3 Germany
- 8.2.4 France
- 8.2.5 U.K.
- 8.2.6 Italy
- 8.2.7 Russia

9 Asia Pacific

9.1 Asia Pacific Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
9.2 Asia Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 9.2.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region (2015-2020)
- 9.2.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region
- 9.2.3 China
- 9.2.4 Japan
- 9.2.5 South Korea
- 9.2.6 India
- 9.2.7 Australia
- 9.2.8 Taiwan
- 9.2.9 Indonesia
- 9.2.10 Thailand
- 9.2.11 Malaysia
- 9.2.12 Philippines
- 9.2.13 Vietnam

10 Latin America

10.1 Latin America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
10.2 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 10.2.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Country
- 10.2.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Country
- 10.2.3 Mexico
- 10.2.4 Brazil
- 10.2.5 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
- 11.2.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country
- 11.2.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country
- 11.2.3 Turkey
- 11.2.4 Saudi Arabia
- 11.2.5 U.A.E

12 Company Profiles

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Next Generation Cancer Diagnostic Devices Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Next Generation Cancer Diagnostic Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)

Segment by Application, the Next Generation Cancer Diagnostic Devices market is segmented into
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Regional and Country-level Analysis
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Next Generation Cancer Diagnostic Devices market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)

Buy now